MedPath

Optimal Timing For Embryo Transfer For Low Responder Patients

Not Applicable
Terminated
Conditions
Infertility
Registration Number
NCT01040247
Lead Sponsor
HaEmek Medical Center, Israel
Brief Summary

Women undergoing in vitro fertilization (IVF) therapy, who are low responder and agree to enter the trial will be randomized to a study group, for whom embryo transfer will be done on the same day as oocyte aspiration and fertilization; and a control group for whom embryo transfer will be performed 48 to 72 hours later, as is the current accepted practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • Patient undergoing IVF
  • Number of mature oocytes equal to or lesser than the maximum number of embryos intended for transfer
Exclusion Criteria
  • Patient nor consenting

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pregnancy14 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

HaEmek Medical Center

🇮🇱

Afula, Israel

HaEmek Medical Center
🇮🇱Afula, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.